Hints and tips:
Related Special Reports
...Novartis had already attempted to shed parts of Sandoz to India’s Aurobindo in 2020, but competition concerns from US regulators scuppered the nearly $1bn deal in 2020....
...“To redress this lack of equity, pharma must expand its focus beyond stewardship and the hunt for replacement antibiotics....
...Indian producers such as Cipla, Aurobindo Pharma and Sun Pharma (with the most US market exposure), are down more than a tenth....
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
....; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA; Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC...
...The states’ lawsuit said that the six generic drug makers – which also include Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma and Mayne Pharma – “entered into illegal conspiracies in order...
...Other groups that have sealed partnerships include GlaxoSmithKline with Dr Reddy’s Laboratories, and Pfizer with Aurobindo and Claris Lifesciences....
...Pfizer, by contrast, has so far opted for partnerships, agreeing to license medicines from Aurobindo and Claris Life Sciences in India, as did GSK with Aspen in South Africa....
...Other companies have sought to forge partnerships to exploit local companies’ commercial presence and skills in manufacturing, including GlaxoSmithKline and Dr Reddy’s, and Pfizer with Aurobindo and Claris...
...“As soon as you talk about local supply chains and markets, the pharma companies break out in a sweat.”...
...Aurobindo will provide it with the rights to market 60 generic drugs in 70 countries, and Claris Lifesciences with 15 injectable medicines....
...He said Aurobindo and Claris would manufacture the drugs, which in most markets would in future be branded as Pfizer products....
...However, GlaxoSmithKline, which holds the patent, had no objections to Aurobindo of India, the manufacturer, making it for Nigeria, under waivers for medicines under the WTO’s trade-related aspects of intellectual...
...It appears the German division of CVC Capital Partners has teamed up with a small Hyderabad-based drugs firm, Aurobindo Pharma, to join the auction....
...Now, according to the new Indian business paper, Mint, the German division of CVC Capital Partners has teamed up with a small Hyderabad-based drugs firm, Aurobindo Pharma, to join the Merck generics auction...
International Edition